Philip S Bernard Selected Research

Philip S Bernard Research Topics

Disease

39	Neoplasms (Cancer) 09/2023 - 08/2002
35	Breast Neoplasms (Breast Cancer) 09/2023 - 01/2004
3	Colonic Neoplasms (Colon Cancer) 12/2019 - 08/2002
2	Pathologic Complete Response 09/2023 - 03/2009
2	Polyps 12/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2016 - 10/2011
2	Triple Negative Breast Neoplasms 01/2013 - 07/2012
2	Carcinoma (Carcinomatosis) 09/2012 - 08/2003
1	Inflammation (Inflammations) 01/2020
1	Adenoma (Adenomas) 12/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2018
1	Obesity 07/2017
1	Overweight 07/2017
1	Carcinogenesis 03/2015
1	Lung Neoplasms (Lung Cancer) 07/2013
1	Adenocarcinoma of Lung 01/2012
1	Disease Progression 12/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2010
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2007
1	Nevus (Nevi) 10/2005
1	Melanoma (Melanoma, Malignant) 10/2005
1	Adenocarcinoma 08/2003

Drug/Important Bio-Agent (IBA)

22	Phenobarbital (Luminal)FDA Link 09/2023 - 01/2006
14	Estrogen ReceptorsIBA 09/2023 - 01/2006
8	ParaffinIBA 12/2019 - 08/2003
7	Formaldehyde (Formol)FDA Link 12/2019 - 03/2007
7	Biomarkers (Surrogate Marker)IBA 12/2019 - 11/2013
5	RNA (Ribonucleic Acid)IBA 12/2019 - 08/2002
5	Progesterone Receptors (Progesterone Receptor)IBA 05/2014 - 05/2009
4	AnthracyclinesIBA 09/2023 - 03/2009
4	Hormones (Hormone)IBA 12/2018 - 05/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2005
4	Tamoxifen FDA LinkGeneric 01/2013 - 05/2009
3	taxaneIBA 09/2023 - 03/2009
3	Messenger RNA (mRNA)IBA 01/2018 - 03/2005
3	human ERBB2 proteinIBA 07/2015 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 08/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 08/2002
2	P-2 (P 2)IBA 09/2023 - 03/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2019 - 04/2013
2	NestinIBA 01/2017 - 11/2013
2	Cetuximab (Erbitux)FDA Link 07/2012 - 07/2007
2	Carboplatin (JM8)FDA LinkGeneric 07/2012 - 07/2007
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2012 - 10/2005
1	Opioid Analgesics (Opioids)IBA 03/2021
1	Proton Pump InhibitorsIBA 03/2021
1	CytokinesIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Drug CombinationsIBA 01/2018
1	Sulindac (Copal)FDA LinkGeneric 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018
1	immune RNA (I-RNA)IBA 01/2017
1	ORALIT (ORS)IBA 07/2015
1	Coloring Agents (Dyes)IBA 05/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2015
1	BiguanidesIBA 03/2015
1	AMP-Activated Protein KinasesIBA 03/2015
1	Metformin (Glucophage)FDA LinkGeneric 03/2015
1	Estrogens (Estrogen)FDA Link 05/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2013
1	7-hydroxystaurosporine (UCN 01)IBA 01/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2013
1	LipidsIBA 09/2012
1	MA 12 (MA12)IBA 08/2012
1	Epirubicin (Ellence)FDA LinkGeneric 04/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2012
1	Fluorouracil (Carac)FDA LinkGeneric 04/2012
1	Methotrexate (Mexate)FDA LinkGeneric 04/2012
1	Tripartite Motif ProteinsIBA 02/2012
1	Indicators and Reagents (Reagents)IBA 10/2011
1	Bortezomib (Velcade)FDA Link 12/2010
1	thiamine triphosphorate (TTP)IBA 12/2010
1	1-dodecylpyridoxal (PLD)IBA 12/2010
1	liposomal doxorubicin (Doxil)FDA Link 12/2010
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2007
1	Melanins (Melanin)IBA 10/2005
1	beta CateninIBA 10/2005
1	Complement System Proteins (Complement)IBA 03/2005
1	Complementary DNA (cDNA)IBA 03/2005
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2004
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2004
1	Adenosine Triphosphatases (ATPase)IBA 01/2004
1	splicing factor 3aIBA 01/2004
1	AlbuminsIBA 08/2003
1	Monoclonal AntibodiesIBA 08/2003
1	OligonucleotidesIBA 08/2002
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2002

Therapy/Procedure

14	Therapeutics 09/2023 - 08/2003
8	Drug Therapy (Chemotherapy) 09/2023 - 03/2009
1	Polypharmacy 03/2021
1	Precision Medicine 05/2019
1	Chemoprevention 01/2018
1	Contraindications 07/2013
1	Investigational Therapies (Experimental Therapy) 08/2003